REstoration of VItamin D in Pulmonary Arterial Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 102 participants.
Also called NCT06258850
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT06258850
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06258850. Randomized; quadruple masking; primary purpose treatment. Start 2024-07-01 (anticipated); primary completion 2027-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REstoration of VItamin D in Pulmonary Arterial Hypertension
- Acronym
- REVIDAH
- Condition
- Pulmonary Artery Hypertension
- Condition
- Vitamin d Deficiency
- Intervention (Drug)
- Calcifediol Oral Capsule
- Intervention (Drug)
- Placebo
- Lead sponsor
- Parc de Salut Mar
- Collaborator
- Universidad Complutense de Madrid
- Collaborator
- Hospital Clinic of Barcelona
- Collaborator
- Hospital Vall d'Hebron
- Collaborator
- Hospital Universitario Marqués de Valdecilla
- Collaborator
- Hospital Universitario de Gran Canaria Doctor Negrín
- Collaborator
- Hospital Universitario La Fe
- Collaborator
- Hospital Universitario Doctor Peset
- Collaborator
- Hospital Universitario Ramon y Cajal
- Collaborator
- Hospitales Universitarios Virgen del Rocío
Record details
- Record id
cardio:ct-nct06258850- Content hash
212c8d4b5494147b5ceca2c43b188db7ce3c614def46b8b6618bebb345526106